EquityZen Growth Technology Fund II LLC - Series 28
Raised
$1M
Investors
17
Min Invest
$20,069
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund II LLC - Series 28 is a Delaware-based pooled investment fund filed by EquityZen Advisors LLC and Philip Haslett under exemptions 506(b) and 3(c). The vehicle raised $1.2M from 17 investors with a $20K minimum investment. This is part of the EquityZen platform, which operates approximately 150 related EDGAR entities focused on private equity investments.
This Series fund follows a typical private equity fund structure using 506(b) exemption with a $20K minimum, positioning it in the accessible accredited investor tier. The per-investor average of approximately $70K and use of 3(c) exemption aligns with standard single-company SPV patterns commonly employed by secondary marketplace platforms.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
